# Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial

> **NCT07164027** · EARLY_PHASE1 · RECRUITING · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **PROCEDURE:** Biopsy of Prostate
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **RADIATION:** Flotufolastat F-18 Gallium
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT07164027
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-14
- **Primary completion:** 2036-01-28
- **Final completion:** 2037-01-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07164027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07164027, "Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07164027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*